Overview: DNPH TestIntroduction: The DNPH Test detects ketones in urine to diagnose metabolic disorders like maple syrup urine disease, causing developmental delays. Following 2023 ACMG guidelines, it uses spectrophotometry for high sensitivity, aiding in metabolic screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in clinical pathology for patients with suspected metabolic disorders.
Other Names: Dinitrophenylhydrazine Assay, Ketone Detection Test.
FDA Status: Laboratory-developed test (LDT), meeting clinical pathology standards for diagnostic accuracy.
Historical Milestone: DNPH testing began in the 1950s with metabolic disorder research. Spectrophotometric methods emerged in the 1970s, and by the 2000s, standardized assays improved accuracy.
Purpose: Diagnoses metabolic disorders, guides treatment, and monitors ketone presence in patients with developmental delays.
Test Parameters: 1. Dinitrophenylhydrazine
Pretest Condition: No fasting required. Collect urine at any time. Report symptoms like developmental delays or unusual urine odor, and list family history of metabolic disorders.
Specimen: 5-20 mL urine (sterile container). Transport in a biohazard bag within 2 hours.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not frozen
Medical History: Document developmental delays, unusual urine odor, or family history of metabolic disorders. Include current medications or dietary restrictions.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for metabolic therapy.
Procedural Considerations: Uses spectrophotometry to detect ketones via DNPH reaction. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Contamination or improper storage can affect results. Dietary factors may influence ketone levels.
Clinical Significance: Positive ketone results suggest metabolic disorders (e.g., MSUD), prompting dietary or medical intervention. Negative results may require further testing.
Specialist Consultation: Consult a metabolic specialist or pediatrician for result interpretation.
Additional Supporting Tests: Amino acid analysis, organic acid testing, or genetic screening to confirm metabolic disorders.
Test Limitations: Non-specific ketone detection may occur in other conditions. Results require clinical correlation.
References: ACMG Metabolic Guidelines, 2023; Journal of Inherited Metabolic Disease, Vockley J, 2022.
